フェーズ I 反応: 炭素ヘテロ原子系およびその他の系の酸化

Secondary and tertiary amines undergo N-dealkylation, an oxidative process that removes alkyl groups and produces a carbinolamine intermediate. This intermediate rearranges to form an N-dealkylated product with a simpler structure. This reaction is common in drugs like tricyclic antidepressants and represents a major metabolic pathway for carbon-nitrogen systems.

Oxidative deamination follows a similar pathway to N-dealkylation but produces a different outcome. While N-dealkylation removes alkyl groups, oxidative deamination results in formation of simpler amines, such as amphetamine from its parent compound. Both reactions involve oxidation of carbon-nitrogen systems but yield distinct metabolic products.

Carbon-sulfur systems undergo multiple oxidative transformations including S-dealkylation, desulfuration, and S-oxidation. These reactions commonly affect sulfonamides and thiols found in various drugs. Understanding these processes is essential for predicting how sulfur-containing medications are metabolized in the body and how physicochemical and chemical properties affect their biotransformation.

Codeine is a classic example of a drug undergoing O-dealkylation, the predominant oxidative reaction in carbon-oxygen systems. This reaction cleaves the ether linkage, removing alkyl groups attached to oxygen atoms. O-dealkylation is a major metabolic pathway for drugs containing carbon-oxygen bonds.

N-oxide formation is an oxidative reaction that occurs in basic nitrogen atoms within drug molecules. This transformation adds an oxygen atom to the nitrogen, creating an N-oxide product. It represents an alternative oxidative pathway for amines that complements N-dealkylation and oxidative deamination reactions in phase I metabolism.

Beyond major pathways, drugs undergo oxidative dehalogenation, as seen with chloroform, and dehydrogenation, like in nifedipine. These miscellaneous reactions modify drug structure through removal of halogen atoms or introduction of double bonds. Such transformations are critical for understanding complete metabolic profiles of diverse pharmaceutical compounds.

N-hydroxylation occurs when nitrogen is non-basic or lacks an α-hydrogen, adding a hydroxyl group to nitrogen. This differs from N-oxide formation, which targets basic nitrogen atoms. Both are oxidative transformations of carbon-nitrogen systems, but they occur under different chemical conditions and produce structurally distinct metabolites.